SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF Portfolio
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BRAVEHEART who wrote (621)2/25/1999 8:02:00 PM
From: BRAVEHEART  Read Replies (2) of 1073
 
Hi Rick,

I have been hoping for an opportunity to ask you if you have formed an opinion of MEDX from a science perspective. Also what is your take on the recent development.

biz.yahoo.com

Finally MEDX recently had a P-3 trial halted because of buffer concerns and adverse reactions. Are you familiar with any other similar cases. Are there typically alternatives as far as changing buffers. Is it a complex process and how would a company typically have to satisfy the FDA in order to restart Phase testing?

Thanks Rick
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News